Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
We are available to assist you 24/7.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Advances in co-opting anti-depressant drugs in glioma therapy. Cell reports. Medicine Pant, A., Lim, M. 2022; 3 (12): 100837
A study by Chryplewicz etal. demonstrated the efficacy of combining tricyclic antidepressant imipramine and anti-VEGF therapy in treating genetically engineered glioma models. Dual therapy synergistically improved vascular integrity, increased autophagy, and modulated the myeloid and lymphoid compartments in glioma.
View details for DOI 10.1016/j.xcrm.2022.100837
View details for PubMedID 36543105